Revise Research and development for IB Business Management (5.7)

R&D is not simply a cost centre; it is a strategic investment in a firm's future competitiveness. For businesses in technology, pharmaceuticals, automotive and consumer goods, a healthy R&D pipeline is often the main source of long-term growth and market leadership. R&D generates new products that differentiate the business, improves processes that cut costs, and creates valuable intellectual property that competitors cannot easily copy. Its importance rises with the pace of change in the market and the intensity of competition: where rivals innovate constantly and product life cycles are short, a firm that neglects R&D watches its products become obsolete.

These two words are constantly confused, and examiners reward candidates who keep them apart. An invention is the creation of something genuinely new — a new product, process or idea — for the first time. An innovation is the successful commercial exploitation of a new idea: actually bringing it to market and making it a success. The crucial point is that an invention only becomes an innovation when it is commercialised. Countless inventions never make a penny because the firm could not produce them cheaply enough, could not protect them from copying, or could not persuade customers to buy. The commercial value lies in innovation, not invention alone — which is why development, marketing and IP protection matter as much as the original breakthrough.

Innovation is not a single thing. The syllabus asks you to distinguish it along two dimensions. The first is WHAT changes: product innovation changes the good or service a business offers, while process innovation changes how it is made or delivered. The second is HOW BIG the change is: incremental innovation makes small, continuous improvements, while disruptive innovation is a radical breakthrough that can reshape a whole market. A business usually pursues a mix — small incremental tweaks to protect today's revenue, alongside bolder bets on disruptive change for tomorrow. Being able to classify a real example correctly, and explain the trade-offs, is exactly what 5.7 questions test.

The strategic pay-off from R&D is competitive advantage — an edge that lets a firm outperform its rivals. R&D can build that edge in two broad ways. Product innovation can differentiate the business, letting it charge premium prices for something customers cannot get elsewhere; if the firm is first to market, it may enjoy a first-mover advantage, capturing customers and setting the standard before rivals catch up. Process innovation can build a cost advantage, letting the firm undercut competitors or earn higher margins at the same price. The durability of the advantage depends on how easily rivals can copy it — which is precisely where intellectual property protection comes in. Without protection, a costly innovation can be imitated within months and the advantage evaporates before the R&D has paid back.

R&D is expensive and risky, so a business needs a way to stop competitors free-riding on its success. Intellectual property (IP) rights are the legal tools that do this, and the syllabus names three. A patent protects a new invention — how something works — giving the owner exclusive rights to make, use and sell it for a limited period (often up to 20 years), after which anyone may copy it. A copyright protects original creative works — writing, music, software code, film, design — from being copied; it protects the expression of an idea, not the idea itself, and lasts a long time automatically. A trademark protects a distinctive brand name, logo or slogan that identifies the business's products; unlike a patent it can be renewed indefinitely. Together these rights let a firm recoup its R&D investment and defend its competitive advantage — though enforcing them can be costly, and protection is territorial and time-limited.

R&D is one of the clearest examples of a decision with large upside and large downside, which is why it is such fertile ground for evaluation questions. The benefits — differentiation, premium pricing, cost savings, new markets, valuable IP and a reputation for innovation — can be transformational. But the costs are high and largely paid up front, often over many years before any revenue appears, and the risks are severe: technical failure (the product never works), commercial failure (it works but customers reject it), imitation (rivals copy before payback), and long, uncertain payback periods that strain cash flow. R&D also carries an opportunity cost — money sunk into research cannot be used to cut prices, pay dividends or expand elsewhere. Whether the investment is worthwhile depends on the industry, the firm's finances, the strength of IP protection and the pace of competition.

R&D\ $intensity = \frac{\text{R\&D expenditure}}{\text{Total revenue}} \times 100$

R&D intensity shows how heavily a firm invests in innovation relative to its size, and is useful for comparing firms or tracking one firm over time. But remember it measures an INPUT: a high ratio signals commitment, not success. The better questions ask what the spending actually produced — new products launched, patents secured, costs saved — because effective, well-managed R&D can beat a bigger but wasteful budget.

R&D shapes strategy. A firm can pursue a differentiation strategy built on a stream of innovative, patent-protected products, or a cost-leadership strategy built on relentless process innovation — but either way, the R&D commitment is a long-term one that locks in spending and shapes the firm's identity for years. It also forces a portfolio choice: how much to invest in low-risk incremental improvements that protect today's revenue versus high-risk disruptive bets on tomorrow's. These decisions affect stakeholders differently, and recognising that spread of interests is where evaluation marks are earned.

Business Management 5.7 is assessed against three objectives: AO1 rewards relevant knowledge of R&D and innovation concepts, AO2 rewards applying that knowledge to the specific business in the stimulus, and AO3 rewards analysis and a balanced evaluation. In the analytic/points scheme each distinct valid point earns credit, but the higher marks on command terms like 'discuss' and 'evaluate' are reserved for answers that combine APPLICATION to context with a BALANCED evaluation that ends in a SUPPORTED JUDGEMENT. Watch how the marks below attach to applied, two-sided reasoning and a justified conclusion — never to a generic list.

R&D connects across the whole course. The competitive advantage it creates links back to strategy and the differentiation-versus-cost choices in the business's overall plan; the heavy up-front spending and long payback feed directly into investment appraisal and sources of finance; and the stakeholder trade-offs echo the conflicts explored in the organisational objectives topic. Master the habit built here — identify the concept, apply it to the specific business, weigh both sides, then commit to a justified judgement — and you have the template that earns marks across every evaluation question in Business Management.